|
Fuster, JL; Cabanas, V; Blanquer, M; Sanchez-Salinas, A; Monserrat-Coll, J; Pascual-Gaquez, JF; Galera, A; Llinares, E; Bermudez-Cortes, M; Moraleda, JM. THE RECENT SINGLE CENTRE EXPERIENCE WITH PEDIATRIC SOLID TUMORS OF A NEW STEM CELL TRANSPLANTATION AND CELL THERAPY UNIT. BONE MARROW TRANSPLANTATION. 2014; 49:S366-S366.
AÑO: 2014; IF: 5.174
|
|
Sánchez-Guiu I, Antón AI, García-Barberá N, Navarro-Fernández J, Martínez C, Fuster JL, Couselo JM, Ortuño FJ, Vicente V, Rivera J, Lozano ML. Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype. Eur J Haematol. 2014 Jan;92(1):49-58. doi: 10.1111/ejh.12203. PubMed PMID: 24112114.
AÑO: 2014; IF: 2.066
|
|
Bueno C, Roldan M, Anguita E, Romero-Moya D, Martín-Antonio B, Rosu-Myles M, del Cañizo C, Campos F, García R, Gómez-Casares M, Fuster JL, Jurado M, Delgado M, Menendez P. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica. 2014 Jul;99(7):1168-75. doi: 10.3324/haematol.2014.103580. PubMed PMID: 24727813; PubMed Central PMCID: PMC4077077.
AÑO: 2014; IF: 5.814
|
|
Fernández de Palencia Espinosa MA, Díaz Carrasco MS, Fuster Soler JL, Ruíz Merino G, De la Rubia Nieto MA, Espuny Miró A. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients. Int J Clin Pharm. 2014 Dec;36(6):1160-9. doi: 10.1007/s11096-014-0011-1. PubMed PMID: 25204258.
AÑO: 2014; IF: 2.305
|
|
Martínez-Laperche C, Gómez-García AM, Lassaletta Á, Moscardó C, Vivanco JL, Molina J, Fuster JL, Couselo JM, de Toledo JS, Bureo E, Madero L, Ramírez M. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse. Am J Hematol. 2013 May;88(5):359-64. doi: 10.1002/ajh.23407. PubMed PMID: 23468276.
AÑO: 2013; IF: 3.477
|